CatalystAlert

Search CatalystAlert

Search for companies, drugs, and catalysts

Search CatalystAlert

Search for companies, drugs, and catalysts

Cancer Network
Original article

<![CDATA[Enrollment Begins for Elritercept Phase 3 Trial in Lower-Risk MDS]]>

Phase 3TAK-226

Read the original article

Published by Cancer Network on September 8, 2026 2:30 PM

Read Original